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Surgery has been reported to suppress cell-mediated immunity; however, the detailed 
mechanisms responsible for this remain unclear. We obtained information on expressions 
of T-cell immunoglobulin domain and mucin domain 3 (TIM-3) and programmed cell 
death 1 (PD-1) on both CD4+ and CD8+ T cells postoperatively from colorectal cancer 
patients and evaluated by multicolor flow cytometry. The functions of CD4+ and CD8+ T 
cells based on TIM-3 and PD-1 expressions were determined by quantitating the concen-
tration of interferon-  (IFN- ) by enzyme-linked immunosorbent assay. The study dem-
onstrated a rapid and significant decrease in number of total lymphocytes, CD4+ T cells 
and CD8+ T cells. These immune cells reached the minimum on day 1 and then increased, 
but still significantly decreased on days 3 and 7. The frequency of PD-1+CD4+ T cells and 
TIM-3+CD4+ T cells significantly increased after colorectal surgery. IFN-  secretion by 
PD-1+TIM-3+CD4+ T cells was significantly decreased compared to secretion by either 
PD-1+TIM3-CD4+ T cells or PD-1−TIM-3−CD4+ T cells. Furthermore, IFN-  secretion 
by PD-1+TIM-3+CD8+ T cells was significantly decreased compared to secretion by either 
PD-1−TIM-3+CD8+ T cells or PD-1−TIM-3−CD8+ T cells. The expression of PD-1 and 
TIM-3 was closely related to impaired cell-mediated immunity that was observed after 
surgery for colorectal cancer. New treatment targeting TIM-3 and PD-1 on CD4+ and 
CD8+ T cells during the perioperative period may provide a breakthrough in the treat-
ment of colorectal cancer patients.
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Colorectal cancer is one of the most prevalent 
solid organ cancers in both men and women. Ap-
proximately one million cases are recorded every 
year worldwide, and over half a million patients 
die of this disease yearly (Parkin et al., 2005). 
Surgical removal of the primary tumor provides 
the best chance of long-term disease-free survival 
for patients with colorectal cancer. Unfortunately, 
a significant number of colorectal cancer patients 
typically develop metastases, even after successful 
resection of the primary tumor. It is now becoming 
clear that surgery itself contributes to development 
of both local recurrences and distant metastases. 
Surgical trauma and the concomitant wound-heal-
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ing processes induce local and systemic changes, 
including impairment of tissue integrity and pro-
duction of inflammatory mediators and angiogenic 
factors. Subsequently, this can lead to immune 
suppression and enhanced growth or adhesion of 
tumor cells, all of which increase the chance of 
exfoliated tumor cells developing into secondary 
malignancies (van der Bij et al., 2009).
 Surgery has been reported to suppress cell-
mediated immunity, which plays a key role in host 
defense against bacterial and viral infections (Gupta 
and Watson, 2001; Jacobi et al., 2002). T cells are 
a critical component of cellular immunity that are 
involved in the recruitment and activation of ef-
fector cells, as well as amplification of the specific 
immune response to pathogens and cancer cells. 
T-cell dysfunctions are characterized by dimin-
ished cytokine production, impaired killing and 
hypoproliferation. According to Wichmann et al. 
(2005), there is a significant decrease in cell num-
ber of lymphocyte subpopulations, such as helper 
T lymphocytes (Th), cytotoxic T lymphocytes and 
natural killer cells after surgery. After conventional 
cholecystectomy, T cells produce significantly less 
interferon-  (IFN- ), tumor necrosis factor-  and 
interleukin-2 (Brune et al., 1999). Surgical stress is 
known to induce a shift in the Th1/Th2 balance to-
ward Th2, which suggests downregulation of cell-
mediated immunity and upregulation of antibody-
mediated immunity after surgery (Decker et al., 
1996). However, the detailed mechanisms respon-
sible for the dysfunction of T cells after surgery 
remain unclear.
 Recent studies have demonstrated that pro-
grammed cell death 1 (PD-1) and T-cell immu-
noglobulin domain and mucin domain 3 (TIM-3) 
expression on CD4+ and CD8+ T cells is closely 
associated with T-cell dysfunction in human im-
munodeficiency virus (HIV), hepatitis C virus 
(HCV) and cancer patients. PD-1 (CD279) was 
identified as a gene that was upregulated in a T-cell 
hybridoma undergoing apoptotic cell death, and 
was thus named PD-1 (Okazaki and Honjo, 2006). 
PD-1 is inducibly expressed on CD4+ T cells, 
CD8+ T cells, natural killer-like T cells, B cells 
and monocytes upon activation (Greenwald et al., 
2005; Okazaki and Honjo, 2006). Recent studies 
have shown that PD-1 is highly expressed by CD8+ 
T cells during chronic lymphocytic choriomeningi-
tis virus infection, and that the PD-1–PD-1-ligand 
(PD-L) pathway plays a major role in regulating 
T-cell exhaustion during infection (Barber et al., 
2006). Furthermore, several new studies suggest a 
role for the PD-1–PD-L pathway in exhaustion of 
virus-specific CD8+ T cells during HIV infection. 
Several reports show that PD-1 expression is elevat-
ed on HIV-specific CD8+ T cells and that blocking 
the PD-1–PD-L pathway leads to increased T-cell 
proliferation and effector cytokine production (Day 
et al., 2006; Petrovas et al., 2006; Trautmann et 
al., 2006). A previous work has shown that PD-L 
is upregulated in HIV infection (Trabattoni et al., 
2003). Collectively, these observations suggest that 
the PD-1–PD-L pathway may indeed be operating 
during chronic HIV infection.
 TIM-3 is a transmembrane protein constitu-
tively expressed on type 1 CD8+ cytotoxic T cells 
(Tc1) in mice and humans (Monney et al., 2002). 
Several lines of evidence support the role of TIM-3 
as an inhibitory molecule that downregulates effec-
tor Th1/Tc1 cell responses. In mice, blocking the 
TIM-3–TIM-3 ligand (TIM-3L) pathway resulted in 
hyperproliferation of Th1-type cells and abrogated 
the induction of peripheral and transplantation 
tolerance (Sabatos et al., 2003; Sanchez-Fueyo et 
al., 2003). TIM-3 interacts with its ligand galec-
tin-9 to induce cell death in Th1 cells (Zhu et al., 
2005). In humans, TIM-3 expression is defective 
in CD4+ T cells producing high levels of IFN- , 
as well as those isolated from the cerebrospinal 
fluid of patients with multiple sclerosis (Koguchi et 
al., 2006). Recently, TIM-3 upregulation has been 
reported in HIV-specific and HCV-specific CD8+ 
T cells in patients with progressive HIV infection 
and chronic hepatitis C, respectively (Jones et al., 
2008; Golden-Mason et al., 2009). TIM-3+ HIV- 
and HCV-specific CD8+ T cells were distinct from 
the PD-1+ CD8+ T cells and exhibited T-cell dys-
function. In addition to virus infection, PD-1 and 
TIM-3 expression on CD4+ and CD8+ T cells are 
also related to T-cell exhaustion in cancer patients 
(Fourcade et al., 2010; Sakuishi et al., 2010).
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 Given that PD-1 and TIM-3 expressions on 
CD4+ and CD8+ T cells are closely associated 
with T-cell dysfunction in HIV, HCV and cancer 
patients, it is likely that these might be related to 
suppression of cell-mediated immunity induced 
after surgery. In the present study, therefore, we 
investigated the expressions of PD-1 and TIM-3 on 
lymphocytes to determine the role of these mol-
ecules in the immune-suppression that occurs after 
operation for colorectal cancer.  
Table 1. Clinicopathologic characteristics in 
colorectal cancer patients in the present study
Clinicopathologic factor n (%)
 
Gender Male 20 (56)
 Female 16  (44)
Age (yr) 66.8 ± 3.1
Procedure Open 11  (30)
 Laparoscopic 25  (70)
Cancer site Cecum 2  (5)
 Ascending 6 (16)
 Transverse 5 (14)
 Descending 1 (3)
 Sigmoid 6 (16)
 Rectum 17 (47)
Depth of invasion* M/SM/MP 16 (44)
 SS/SE/SI (A1/A2/AI) 20 (56)
Lymph node metastasis Absent 26 (72)
 Present 10 (28)
Lymphatic invasion Absent 7 (19)
 Present 29 (81)
Vascular invasion Absent 8 (22)
 Present 28 (78)
Liver metastasis Absent 35 (97)
 Present 1 (3)
Lung metastasis Absent 34  (94)
 Present 2 (6)
Stage of disease 0 2 (6)
 I 12 (33)
 II 11 (30)
 III 8 (22)
 IV 3 (8)
* M,  tumor invasion of mucosa; 
 SM,  tumor invasion of submucosa; 
 MP,  tumor invasion of muscularis propria; 
 SS,  tumor invasion of subserosa.
 SE,  tumor invasion of serosa; 
 SI,  direct tumor invasion of other organs or structures; 
 A1,  tumor invasion through muscularis propria into a non-
peritonealized part; 
 A2, tumor invasion of non-peritonealized, pericolic or peri-
rectal tissues;  
 AI, direct tumor invasion of other organs or structures. 
 
Materials and Methods
Patients and normal donors 
 
Thirty-six patients (20 males and 16 females), 
treated at the Tottori University Hospital and patho-
logically diagnosed with colorectal cancer, were 
enrolled in this study. None of the patients received 
radiotherapy, chemotherapy or other medical in-
terventions before surgery. Informed consent for 
blood donations was obtained from all individuals. 
The clinicopathological findings were determined 
according to the Japanese Classification of Colorec-
tal Carcinoma (Japanese Society for Cancer of the 
Colon and Rectum, 2009). The clinicopathological 
characteristics of the patients enrolled in the pres-
ent study are shown in Table 1.
 
Preparation of peripheral blood mononucle-
ar cells
 
Approximately 30 mL of peripheral blood was 
drawn from the patients before surgery as well 
as on days 1, 3, 7 and 30 after surgery, and blood 
samples were prepared by centrifugation over a Fi-
coll-Paque (Pharmacia, Uppsala, Sweden) density 
gradient.
 
Flow cytometry analysis
 
Fluorescence-activated cell sorting (FACS) analy-
sis was performed using an FACS Calibur (Becton 
Dickinson, Franklin Lakes, NJ). The following 
antibodies were used to determine cell phenotype: 
anti-CD4-FITC, anti-CD8-FITC, anti-PD-1-PE 
(BD PharMingen, Franklin Lakes, NJ), anti-TIM-
3-PE (R&D Systems, Minneapolis, MN) and anti-
CD3-PE-Cy5 (Biolegend, San Diego, CA).
 
Measurement of IFN-  concentrations
 
CD4+ or CD8+ T cells were sorted based on TIM-
3−PD-1−, TIM-3+PD-1−, TIM-3−PD-1+ and TIM-
3+PD-1+ phenotype. Each population was seeded 
in anti-CD3 antibody-coated 96-well plates (1 × 
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104 cells/well; Nunc A/S, Roskilde, Denmark). 
After 48 h incubation, supernatants were collected. 
The IFN-  concentrations of the supernatants were 
measured by enzyme-linked immunosorbent assay 
(ELISA) using a human IFN-  ELISA Kit (R&D 
Systems).
 
Media
 
Complete culture medium consisting of RPMI 
1640 (Invitrogen, Carlsbad, CA), 1% L-gluta-
mine (Invitrogen), 1% penicillin/streptomy-
cin (Invitrogen), 2.5% HEPES buffer solution 
(Invitrogen), 1% sodium pyruvate (Sigma-Aldrich, 
St. Louis, MO), 1% essential amino acids (Sigma-
Aldrich) and 20% fetal bovine serum (Sigma-
Aldrich) was used.
 
  
 
Statistical analysis 
 
All values are expressed as mean ± SD.  To de-
termine statistical differences between 2 groups, 
either paired or unpaired t-tests were used. The 
accepted level of significance was P < 0.05. The 
GraphPad Prism software (GraphPad Software, La 
Jolla, CA) was used for all statistical analyses.
 
 
Results
 
 
  
Absolute leukocyte and lymphocyte counts 
and C-reactive protein levels after colorectal 
cancer operation
 
The number of total leukocytes increased post-
operatively and reached a maximum on day 1 
(Fig. 1a). The number of neutrophils also increased 
postoperatively, reached a maximum on day 1 and 
then decreased, but still significantly elevated on 
day 3 (Fig. 1b). Further, a significant increase in C-
reactive protein levels was also observed on days 
1, 3 and 7 compared with preoperative values (Fig. 
1c). On the other hand, a rapid and significant de-
crease in number of total lymphocytes (Fig. 2a), 
CD4+ T cells (Fig. 2b) and CD8+ T cells (Fig. 2c) 
was also observed. These cells reached a minimum 
on day 1 and then increased, but still significantly 
decreased on days 3 and 7.
 
 
 
PD-1 and TIM-3 expressions on CD4+ and 
CD8+ T cells after colorectal cancer operation
 
Figure 3a shows representative results of PD-1 and 
TIM-3 expressions on CD4+ T cells in peripheral 
blood obtained from colorectal cancer patients on 
postoperative day 3 by FACS. PD-1 and TIM-3 
expressions on both CD4+ and CD8+ T cells was 
Fig. 1. Changes in number of total leukocytes (a), neutrophil count (b) and serum concentration of C-reactive protein (c) 
after surgery. CRP, C-reactive protein; POD, postoperative day; Pre, preoperation.
Comparison with 
the Pre level:
*** P < 0.001.
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Fig. 2. Changes in number of total lymphocytes (a), CD4+ T cells (b) and CD8+ T cells (c) after surgery. POD, postop-
erative day; Pre, preoperation.
Fig. 3. FACS analysis of leukocytes obtained from patients after surgery. 
a Representative results of PD-1 and TIM-3 expressions on CD4+ T cells in peripheral blood obtained from colorec-
tal cancer patients on postoperative day 3 by FACS. 
b Changes in PD-1 expression on CD4+ T cells after surgery. 
c Changes in TIM-3 expression on CD4+ T cells after surgery.
FACS, fluorescence-activated cell sorting; PD-1, programmed cell death 1; TIM-3, T-cell immunoglobulin domain and 
mucin domain 3; POD, postoperative day; Pre, preoperation.
examined and the frequency of PD-1+CD4+ T cells 
(Fig. 3b) and TIM-3+CD4+ T cells (Fig. 3c) sig-
nificantly increased after colorectal surgery. Figure 
4a shows representative results of PD-1 and TIM-
3 expressions on CD8+ T cells in peripheral blood 
obtained from colorectal cancer patients on post-
operative day 3 by FACS. Moreover, a significant 
increase in the frequency of PD-1+CD8+ T cells 
(Fig. 4b) and TIM-3+CD8+ T cells (Fig. 4c) was 
also observed after colorectal cancer operation.
 
 
 
Functional differences of CD4+ and CD8+ 
T cells depending on PD-1 and TIM-3 ex-
pressions
 
Each phenotype of CD4+ and CD8+ T cells based 
on PD-1 and TM-3 expressions was sorted, and 
the function of each phenotype was determined 
by measuring IFN-  secretion. IFN-  secretion by 
PD-1+TIM-3+CD4+ T cells was significantly less 
than that by either PD-1+TIM-3–CD4+ T cells or 
*** P < 0.001.
  ** P < 0.01.
    * P < 0.05.
Comparison with 
the Pre level:
Comparison with 
the Pre level:
*** P < 0.001.
  ** P < 0.01.
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PD-1–TIM-3–CD4+ T cells (Fig. 5a). Furthermore, 
IFN-  secretion by PD-1+TIM-3+CD8+ T cells was 
significantly less than that by either PD-1–TIM-
3+CD8+ T cells or PD-1–TIM-3–CD8+ T cells (Fig. 
5b).
 
 
Discussion
 
During the perioperative and postoperative peri-
ods, a complex biologic response takes place in 
response to surgical stress. This response is in-
tended to restore homeostasis as one aspect of host 
defenses against surgical stress. Thus, it is a very 
important response for the host. On the other hand, 
surgical stress induces suppression of cell-mediated 
immunity that is harmful to patients with cancer 
who underwent operation, since it may diminish a 
patient’s ability to prevent postoperative infections. 
Of importance is that surgical stress-induced sup-
pression of cell-mediated immunity may place a 
patient at higher risk for tumor recurrence. To as-
sess postoperative cell-mediated immune function 
in the present study, the absolute number of circu-
Fig. 5. IFN-  productions by CD4+ T cells (a) and CD8+ 
T cells (b) based on PD-1 and TIM-3 expressions. IFN- , 
interferon- ; PD-1, programmed cell death 1; TIM-3, T-
cell immunoglobulin domain and mucin domain 3. 
Fig. 4. FACS analysis of leukocytes obtained after surgery. 
a Representative results of PD-1 and TIM-3 expressions on CD8+ T cells in peripheral blood obtained from colorec-
tal cancer patients on postoperative day 3 by FACS. 
b Changes in PD-1 expression on CD8+ T cells after surgery. 
c Changes in TIM-3 expression on CD8+ T cells after surgery.
FACS, fluorescence-activated cell sorting; PD-1, programmed cell death 1; TIM-3, T-cell immunoglobulin domain and 
mucin domain 3; POD, postoperative day; Pre, preoperation.
*** P < 0.001.
  ** P < 0.01.
    * P < 0.05.
Comparison with 
the Pre level:
Comparison with the PD-1+TIM-3+ level: *P < 0.05.
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lating immunocompetent cells (CD4+ and CD8+ T 
cells) was measured, since the absolute number of 
circulating immunocompetent cells have been con-
sidered good indicators of the individual patient’s 
cell-mediated immune function. In the present 
patients, the absolute number of total lymphocytes, 
CD4+ T cells and CD8+ T cells significantly de-
creased after colorectal cancer operation. These re-
sults showed evidence of impaired function of cell-
mediated immunity after operation, consistently 
with a previous report by Wichmann et al. (2005).
 Although there are numerous reports demon-
strating inadequate cellular immunity after surgery, 
most studying the effect of surgical trauma on im-
mune function have generally assessed differences 
in cell number and activity of immune cell subsets, 
as well as determined levels of circulating factors 
and mRNA expression of select genes (Hamid et 
al., 1984; Hansbrough et al., 1984; Faist et al., 1986; 
Ogawa et al., 2000; Kalff et al., 2003). However, 
the detailed mechanisms responsible for these de-
fects in cellular immunity remain unclear. There-
fore, we determined PD-1 and TIM-3 expressions 
on CD4+ and CD8+ T cells to demonstrate one 
mechanism likely responsible for impaired cell-me-
diated immunity after colorectal surgery. Our data 
clearly demonstrated that PD-1 expression on both 
CD4+ and CD8+ T cells significantly increased 
after operation. Furthermore, TIM-3 expression 
on both CD4+ and CD8+ T cells also significantly 
increased after operation. Of importance is that 
IFN-  production by CD4+ and CD8+ T cells was 
related to TIM-3 and PD-1 expressions on CD4+ 
and CD8+ T cells in the present study, indicating 
that TIM-3+ PD-1+ CD4+ and CD8+ T cells are 
highly dysfunctional compared with other CD4+ 
and CD8+ T cells. These data indicate that both 
TIM-3 and PD-1 expressions on CD4+ and CD8+ 
T cells is related to impaired function of these cells 
after operation.
 Laparoscopic-assisted colectomy has gained 
acceptance for the treatment of colorectal cancer 
patients. The main advantage of laparoscopic sur-
gery over open surgery is decreased invasiveness 
that results in a rapid return to preoperative activ-
ity levels and significantly shorter hospitalization. 
With regard to prognosis, some prospective ran-
domized clinical trials have suggested that there 
were no differences between laparoscopic and 
open surgery (Guillou et al., 2005; Veldkamp et al., 
2005). Of importance is that a randomized clinical 
trial demonstrated the prognosis of patients who 
underwent laparoscopic surgery is significantly bet-
ter than those who underwent open surgery (Lacy 
et al., 2008). This might be due to well preserved 
cell-mediated immunity in patients who underwent 
laparoscopic surgery. In fact, our preliminary data 
indicated that TIM-3 expression on CD4+ and 
CD8+ T cells obtained from patients who under-
went laparoscopic surgery was significantly lower 
than that obtained from patients who underwent 
open surgery, indicating that cell-medicated im-
munity is well preserved in patients who underwent 
laparoscopic surgery compared with those who 
underwent open surgery. Further investigations are 
required to clearly demonstrate this matter.
 Surgery induces tumor cell dissemination, 
and handling of the tumor during resection can 
result in the spilling of tumor cells, as free float-
ing tumor cells in the peritoneum, circulation and 
liver increase (Weitz et al., 1999; Conzelmann et 
al., 2005). Therefore, suppression of cell-mediated 
immunity after operation for colorectal cancer may 
place the patient at higher risk for tumor recur-
rence. In fact, according to several clinical studies 
that analyzed peri- and post-operatively obtained 
blood, tumor cell presence is a strong predictor of 
colorectal cancer recurrence (Koch et al., 2005; 
Allen-Mersh et al., 2007). Our data clearly demon-
strated that both TIM-3 and PD-1 expressions were 
related to impaired function of T cells after opera-
tion for colorectal cancer. Therefore, PD-1 and 
TIM-3 might be good targets to restore impaired 
cell-mediated immunity after operation for colorec-
tal cancer. In fact, blockade of both the TIM-3–
TIM-3L and PD-1–PD-L pathways reverses the 
function of T cells, and is effective in controlling 
tumor growth.
 In conclusion, PD-1 and TIM-3 expressions 
are closely related to the impaired cell-mediated 
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immunity that is observed after surgery -for 
colorectal cancer, and the development of specific 
treatments targeting TIM-3 and PD-1 on CD4+ and 
CD8+ T cells during the perioperative period may 
provide a breakthrough in the treatment of colorec-
tal cancer patients.
 
References
  
 1 Allen-Mersh TG, McCullough TK, Patel H, Wharton 
RQ, Glover C, Jonas SK. Role of circulating tumour 
cells in predicting recurrence after excision of primary 
colorectal carcinoma. Br J Surg 2007;94:96–105.
 2 Barber DL, Wherry EJ, Masopust D, Zhu B, Allison 
JP, Sharpe AH, et al. Restoring function in exhausted 
CD8 T cells during chronic viral infection. Nature 
2006;439:682–687.
 3 Brune IB, Wilke W, Hensler T, Holzmann B, Siewert 
JR. Downregulation of T helper type 1 immune re-
sponse and altered pro-inflammatory and anti-inflam-
matory T cell cytokine balance following conventional 
but not laparoscopic surgery. Am J Surg 1999;177:55–
60.
 4 Conzelmann M, Linnemann U, Berger MR. Detection 
of disseminated tumour cells in the liver of cancer pa-
tients. Eur J Surg Oncol 2005;31:977–985.
 5 Day CL, Kaufmann DE, Kiepiela P, Brown JA, Mood-
ley ES, Reddy S, et al. PD-1 expression on HIV-specific 
T cells is associated with T-cell exhaustion and disease 
progression. Nature 2006;443:350–354.
 6 Decker D, Schondorf M, Bidlingmaier F, Hirner A, 
von Ruecker AA. Surgical stress induces a shift in the 
type-1/type-2 T-helper cell balance, suggesting down-
regulation of cell-mediated and up-regulation of anti-
body-mediated immunity commensurate to the trauma. 
Surgery 1996;119:316–325.
 7 Faist E, Kupper TS, Baker CC, Chaudry IH, Dwyer J, 
Baue AE. Depression of cellular immunity after major 
injury. Its association with posttraumatic complications 
and its reversal with immunomodulation. Arch Surg 
1986;121:1000–1005.
 8 Fourcade J, Sun Z, Benallaoua M, Guillaume P, 
Luescher IF, Sander C, et al. Upregulation of Tim-3 
and PD-1 expression is associated with tumor antigen-
specific CD8+ T cell dysfunction in melanoma patients. 
J Exp Med 2010;207:2175–2186.
 9 Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, 
Smith AM, et al. Short-term endpoints of conventional 
versus laparoscopic-assisted surgery in patients with 
colorectal cancer (MRC CLASICC trial): multicentre, 
randomised controlled trial. Lancet 2005;365:1718–
1726.
10 Gupta A, Watson DI. Effect of laparoscopy on immune 
function. Br J Surg 2001;88:1296–1306.
11 Golden-Mason L, Palmer BE, Kassam N, Townshend-
Bulson L, Livingston S, McMahon BJ, et al. Negative 
immune regulator Tim-3 is overexpressed on T cells 
in hepatitis C virus infection and its blockade res-
cues dysfunctional CD4+ and CD8+ T cells. J Virol 
2009;83:9122–9130.
12 Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family 
revisited. Annu Rev Immunol 2005;23:515–548.
13 Hamid J, Bancewicz J, Brown R, Ward C, Irving MH, 
Ford WL. The significance of changes in blood lympho-
cyte populations following surgical operations. Clin Exp 
Immunol 1984;56:49–57.
14 Hansbrough JF, Bender EM, Zapata-Sirvent R, Anderson 
J. Altered helper and suppressor lymphocyte popula-
tions in surgical patients. A measure of postoperative 
immunosuppression. Am J Surg 1984;148:303–307.
15 Jacobi CA, Wenger F, Opitz I, Muller JM. Immunologic 
changes during minimally invasive surgery. Dig Surg 
2002;19:459–463. 
16  Japanese Society for Cancer of the Colon and Rectum, 
the.  Japanese classification of colorectal carcinoma. 2nd 
English ed. Tokyo: Kanehara; 2009.
17 Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha 
AR, Long BR, et al. Tim-3 expression defines a novel 
population of dysfunctional T cells with highly elevated 
frequencies in progressive HIV-1 infection. J Exp Med 
2008;205:2763–2779.
18 Kalff JC, Turler A, Schwarz NT, Schraut WH, Lee KK, 
Tweardy DJ, et al. Intra-abdominal activation of a local 
inflammatory response within the human muscularis 
externa during laparotomy. Ann Surg 2003;237:301–315.
19 Koch M, Kienle P, Hinz U, Antolovic D, Schmidt J, 
Herfarth C, et al. Detection of hematogenous tumor cell 
dissemination predicts tumor relapse in patients under-
going surgical resection of colorectal liver metastases. 
Ann Surg 2005;241:199–205.
20 Koguchi K, Anderson DE, Yang L, O’Connor KC, 
Kuchroo VK, Hafler DA. Dysregulated T cell expression 
of TIM3 in multiple sclerosis. J Exp Med 2006;203:1413–
1418.
21 Lacy AM, Delgado S, Castells A, Prins HA, Arroyo V, 
Ibarzabal A, et al. The long-term results of a random-
ized clinical trial of laparoscopy-assisted versus open 
surgery for colon cancer. Ann Surg 2008;248:1–7.
22 Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, 
Chernova T, et al. Th1-specific cell surface protein Tim-
3 regulates macrophage activation and severity of an 
autoimmune disease. Nature 2002;415:536–541.
23 Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi 
K, Shimakawa T, et al. Suppression of cellular immu-
nity by surgical stress. Surgery 2000;127:329–336.
24 Okazaki T, Honjo T. The PD-1-PD-L pathway in immu-
nological tolerance. Trends Immunol 2006;27:195–201.
25 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer 
statistics, 2002. CA Cancer J Clin 2005;55:74–108.
9Immunosuppression after colorectal surgery
26 Petrovas C, Casazza JP, Brenchley JM, Price DA, 
Gostick E, Adams WC, et al. PD-1 is a regulator of 
virus-specific CD8+ T cell survival in HIV infection. J 
Exp Med 2006;203:2281–2292.
27 Sabatos CA, Chakravarti S, Cha E, Schubart A, 
Sanchez-Fueyo A, Zheng XX, et al. Interaction of Tim-
3 and Tim-3 ligand regulates T helper type 1 responses 
and induction of peripheral tolerance. Nat Immunol 
2003;4:1102–1110.
28 Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, 
Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 
pathways to reverse T cell exhaustion and restore anti-
tumor immunity. J Exp Med 2010;207:2187–2194.
29 Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, 
Zheng XX, Sabatos CA, et al. Tim-3 inhibits T helper 
type 1-mediated auto- and alloimmune responses and 
promotes immunological tolerance. Nat Immunol 
2003;4:1093–1101.
30 Trabattoni D, Saresella M, Biasin M, Boasso A, 
Piacentini L, Ferrante P, et al. B7-H1 is up-regulated in 
HIV infection and is a novel surrogate marker of disease 
progression. Blood 2003;101:2514–2520.
31 Trautmann L, Janbazian L, Chomont N, Said EA, 
Gimmig S, Bessette B, et al. Upregulation of PD-1 ex-
pression on HIV-specific CD8+ T cells leads to revers-
ible immune dysfunction. Nat Med 2006;12:1198–1202.
32 van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, 
Coffey JC, van Egmond M. The perioperative period is 
an underutilized window of therapeutic opportunity in 
patients with colorectal cancer. Ann Surg 2009;249:727–
734.
33 Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier 
G, Bonjer HJ, et al. Laparoscopic surgery versus open 
surgery for colon cancer: short-term outcomes of a ran-
domised trial. Lancet Oncol 2005;6:477–484.
34 Weitz J, Kienle P, Magener A, Koch M, Schrodel A, 
Willeke F, et al. Detection of disseminated colorectal 
cancer cells in lymph nodes, blood and bone marrow. 
Clin Cancer Res 1999;5:1830–1836.
35 Wichmann MW, Huttl TP, Winter H, Spelsberg F, 
Angele MK, Heiss MM, et al. Immunological effects of 
laparoscopic vs open colorectal surgery: a prospective 
clinical study. Arch Surg 2005;140:692–697.
36 Zhu C, Anderson AC, Schubart A, Xiong H, Imitola 
J, Khoury SJ, et al. The Tim-3 ligand galectin-9 nega-
tively regulates T helper type 1 immunity. Nat Immunol 
2005;6:1245–1252.
 
Received December 22, 2011; accepted January 4, 2012
Corresponding author: Yosuke Arai
